Skip to main content
Clinical Trials/NCT05325918
NCT05325918
Completed
Not Applicable

HIF-1 Alpha, VEGF and MMP-8 Levels in Peri-implant Crevicular Fluid of Smokers Versus Non Smokers

Future University in Egypt1 site in 1 country14 target enrollmentAugust 29, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Peri-Implantitis
Sponsor
Future University in Egypt
Enrollment
14
Locations
1
Primary Endpoint
Measurement of levels of HIF-1 Alpha, VEGF and MMP-8 in peri-implant crevicular fluid
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

Smoking is a major risk factor for developing peri-implantitis so the current study is comparing inflammatory markers in smokers versus non smokers to know if they have a potential role in pathogenesis of peri-implantitis

Detailed Description

Peri -implant crevicular fluid was obtained from seven smoker patients and then compared to peri-implant crevicular fluid from seven non smoker individuals. The peri-implant crevicular fluid was obtained using periopaper strips then analyzed using ELISA kits of these markers; HIF-1 Alpha, VEGF and MMP-8

Registry
clinicaltrials.gov
Start Date
August 29, 2021
End Date
January 30, 2022
Last Updated
4 years ago
Study Type
Observational
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Sarah Elkot

Lecturer of Oral Medicine, Periodontology and Diagnosis, Faculty of Oral and Dental Medicine, Future University in Egypt, Cairo, Egypt.

Future University in Egypt

Eligibility Criteria

Inclusion Criteria

  • Medically free patients
  • Individuals with restored implants placed one year or more before study enrollment
  • Both genders
  • Age range 20-50 years old

Exclusion Criteria

  • Pregnant Females
  • Lactating females

Outcomes

Primary Outcomes

Measurement of levels of HIF-1 Alpha, VEGF and MMP-8 in peri-implant crevicular fluid

Time Frame: Baseline

Markers collected using periopaper strips

Study Sites (1)

Loading locations...

Similar Trials